Deferred Tax Assets, Valuation Allowance of SUPERNUS PHARMACEUTICALS, INC. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
SUPERNUS PHARMACEUTICALS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • SUPERNUS PHARMACEUTICALS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $590,223,000, a 785% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $590,223,000 +$523,498,000 +785% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q4 2024 $66,725,000 +$5,859,000 +9.6% 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q4 2023 $60,866,000 +$1,268,000 +2.1% 31 Dec 2023 10-K 02 Mar 2026 2025 FY
Q4 2022 $59,598,000 -$10,931,000 -15% 31 Dec 2022 10-K 02 Mar 2026 2025 FY
Q4 2021 $70,529,000 +$69,947,000 +12018% 31 Dec 2021 10-K 25 Feb 2025 2024 FY
Q4 2020 $582,000 +$571,000 31 Dec 2020 10-K 09 Mar 2023 2022 FY
Q2 2020 $70,500,000 09 Jun 2020 10-K 13 Apr 2022 2021 FY
Q4 2019 $11,000* +$2,000 31 Dec 2019 10-K 09 Mar 2023 2022 FY
Q4 2018 $9,000* 31 Dec 2018 10-K 13 Apr 2022 2021 FY
Q4 2015 $60,090,000 -$1,787,000 -2.9% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q4 2014 $61,877,000 +$2,054,000 +3.4% 31 Dec 2014 10-K/A 20 Jan 2017 2015 FY
Q4 2013 $59,823,000 +$21,601,000 +57% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q4 2012 $38,222,000 +$17,691,000 +86% 31 Dec 2012 10-K 21 Mar 2014 2013 FY
Q4 2011 $20,531,000 31 Dec 2011 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.